CD1-MR1 2015*
Chairs: Agnes Lehuen & Adam Uldrich
How stress related responses modulate iNKT cell function (#71)
8:00 AM
iNKT cells in the control and therapeutic reprogramming of the tumor microenvironment (#72)
8:25 AM
Response of tumour cells and adaptive and innate immune cells to shortage of essential amino acids in the local microenvironment (#73)
8:50 AM
NKT cells can enhance Th1-based anti-tumour immunity to advanced cancers in vaccine models and in patients (#74)
9:05 AM
Harnessing NKT cells to promote T cell responses to vaccination (#75)
9:20 AM
Development of atherosclerotic lesion in mice deficient for both CD1d- and MR1-restricted NKT cells (#76)
9:35 AM